ALUMIS INC. — insider transactions
21 transactions on record · ALMS · CIK 1847367
Aggregates
computed from the filings belowPurchases, 12m
4
count of open-market buys
Sales, 12m
17
count of open-market sales
Buy / sell ratio, 12m
0.24
purchases per sale
Distinct insiders, 12m
7
Bought, 3m
$10.7M
Sold, 3m
$1M
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$2.9M
2026-09-08
Director share, 12m
28.6%
of transactions where role is stated
Current run
6 sells
consecutive same-direction transactions
Net 3m flow
$9.7M
purchases minus sales
Total on record
21
Transactions
21 most recent shown| Disclosed | Recorded (UTC) | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-04 | 2026-11-05 03:17:45.224 UTC | 2026-11-02 | 2 | Hardiman Roy C. | Strategy Ofcr | Open market sale | 652 | $6.52 | $4.3K | filing |
| 2026-11-04 | 2026-11-05 03:17:45.817 UTC | 2026-11-02 | 2 | Drappa Jorn | Chief Medical Officer | Open market sale | 593 | $6.52 | $3.9K | filing |
| 2026-11-04 | 2026-11-05 03:17:45.618 UTC | 2026-11-02 | 2 | Goldstein David M | Chief Scientific Officer | Open market sale | 629 | $6.52 | $4.1K | filing |
| 2026-11-04 | 2026-11-05 03:17:46.220 UTC | 2026-11-02 | 2 | Pangali Sanam | Chief Legal Officer | Open market sale | 332 | $6.52 | $2.2K | filing |
| 2026-11-04 | 2026-11-05 03:17:45.418 UTC | 2026-11-02 | 2 | Schroer John R. | Chief Financial Officer | Open market sale | 794 | $6.52 | $5.2K | filing |
| 2026-11-04 | 2026-11-05 03:17:46.019 UTC | 2026-11-02 | 2 | Bradley Mark Christopher | Chief Development Officer | Open market sale | 623 | $6.52 | $4.1K | filing |
| 2026-09-09 | 2026-09-10 02:27:56.281 UTC | 2026-09-04 | 5 | AKKARAJU SRINIVAS | Director | Open market purchase | 220,070 | $11.17 | $2.5M | filing |
| 2026-09-09 | 2026-09-10 02:27:56.281 UTC | 2026-09-08 | 1 | AKKARAJU SRINIVAS | Director | Open market sale | 48,065 | $10.55 | $507K | filing |
| 2026-09-09 | 2026-09-10 02:27:56.281 UTC | 2026-09-04 | 5 | AKKARAJU SRINIVAS | Director | Open market purchase | 220,070 | $11.17 | $2.5M | filing |
| 2026-09-09 | 2026-09-10 02:27:56.281 UTC | 2026-09-08 | 1 | AKKARAJU SRINIVAS | Director | Open market purchase | 273,291 | $10.63 | $2.9M | filing |
| 2026-09-09 | 2026-09-10 02:27:56.281 UTC | 2026-09-08 | 1 | AKKARAJU SRINIVAS | Director | Open market sale | 48,066 | $10.55 | $507K | filing |
| 2026-09-09 | 2026-09-10 02:27:56.281 UTC | 2026-09-08 | 1 | AKKARAJU SRINIVAS | Director | Open market purchase | 273,290 | $10.63 | $2.9M | filing |
| 2026-08-05 | 2026-08-06 03:45:53.733 UTC | 2026-08-03 | 2 | Pangali Sanam | Chief Legal Officer | Open market sale | 1,364 | $26.37 | $36K | filing |
| 2026-08-05 | 2026-08-06 03:45:52.961 UTC | 2026-08-03 | 2 | Hardiman Roy C. | Chief Business & Strategy Ofcr | Open market sale | 2,692 | $26.37 | $71K | filing |
| 2026-08-05 | 2026-08-06 03:45:53.004 UTC | 2026-08-03 | 2 | Schroer John R. | Chief Financial Officer | Open market sale | 3,282 | $26.37 | $86.5K | filing |
| 2026-08-05 | 2026-08-06 03:45:53.059 UTC | 2026-08-03 | 2 | Goldstein David M | Chief Scientific Officer | Open market sale | 2,596 | $26.37 | $68.5K | filing |
| 2026-08-05 | 2026-08-06 03:45:53.639 UTC | 2026-08-03 | 2 | Drappa Jorn | Chief Medical Officer | Open market sale | 2,447 | $26.37 | $64.5K | filing |
| 2026-08-05 | 2026-08-06 03:45:53.684 UTC | 2026-08-03 | 2 | Bradley Mark Christopher | Chief Development Officer | Open market sale | 2,572 | $26.37 | $67.8K | filing |
| 2026-07-08 | 2026-07-26 13:46:14.012 UTC | 2026-07-06 | 2 | Pangali Sanam | Chief Legal Officer | Exercise of derivative | 5,000 | $0.00 | — | filing |
| 2026-07-08 | 2026-07-26 13:46:14.012 UTC | 2026-07-06 | 2 | Pangali Sanam | Chief Legal Officer | Open market sale | 5,000 | $28.00 | $140K | filing |
| 2026-07-08 | 2026-07-26 13:46:14.012 UTC | 2026-07-06 | 2 | Pangali Sanam | Chief Legal Officer | Exercise of derivative | 5,000 | $5.06 | $25.3K | filing |